Market Cap 2.27M
Revenue (ttm) 420,000.00
Net Income (ttm) -16.64M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -3,961.90%
Debt to Equity Ratio 0.20
Volume 166,400
Avg Vol 1,323,714
Day's Range N/A - N/A
Shares Out 1.67M
Stochastic %K 4%
Beta -1.41
Analysts Strong Buy
Price Target $2.00

Company Profile

Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also offers LockeT, a suture retention device that temporarily secure s...

Industry: Medical Devices
Sector: Healthcare
Phone: 973 691 2000
Address:
1670 Highway 160 West, Suite 205, Fort Mill, United States
Joby099
Joby099 Mar. 13 at 3:23 PM
0 · Reply
jstocks100
jstocks100 Mar. 13 at 3:22 PM
0 · Reply
LeGosseuxDeBois
LeGosseuxDeBois Mar. 13 at 2:02 PM
$VTAK borrow rate has jsut doubled. Now at 227.92
0 · Reply
Joby099
Joby099 Mar. 13 at 8:39 AM
0 · Reply
Joby099
Joby099 Mar. 12 at 8:12 PM
0 · Reply
Joby099
Joby099 Mar. 12 at 8:12 AM
0 · Reply
Joby099
Joby099 Mar. 11 at 7:58 PM
0 · Reply
Joby099
Joby099 Mar. 11 at 3:22 PM
0 · Reply
Parobull
Parobull Mar. 11 at 1:59 PM
$ATPC $MRNO $VTAK POLA sitting right in the defense + drone tech narrative. Power systems used in military vehicles, robotics, and aerospace platforms. With drones becoming central to modern warfare and defense spending rising globally, small caps in this ecosystem can get attention quickly.…
0 · Reply
Stackdoe101
Stackdoe101 Mar. 11 at 1:31 PM
0 · Reply
Latest News on VTAK
Catheter Precision Divests Non-Core Assets As It Shifts Focus

Feb 19, 2026, 10:21 AM EST - 24 days ago

Catheter Precision Divests Non-Core Assets As It Shifts Focus


Catheter Precision, Inc. Comments on Recent Market Activity

Jun 12, 2025, 2:14 PM EDT - 9 months ago

Catheter Precision, Inc. Comments on Recent Market Activity


Catheter Precision, Inc. Receives Chinese Patent for LockeT

Sep 24, 2024, 8:30 AM EDT - 1 year ago

Catheter Precision, Inc. Receives Chinese Patent for LockeT


Joby099
Joby099 Mar. 13 at 3:23 PM
0 · Reply
jstocks100
jstocks100 Mar. 13 at 3:22 PM
0 · Reply
LeGosseuxDeBois
LeGosseuxDeBois Mar. 13 at 2:02 PM
$VTAK borrow rate has jsut doubled. Now at 227.92
0 · Reply
Joby099
Joby099 Mar. 13 at 8:39 AM
0 · Reply
Joby099
Joby099 Mar. 12 at 8:12 PM
0 · Reply
Joby099
Joby099 Mar. 12 at 8:12 AM
0 · Reply
Joby099
Joby099 Mar. 11 at 7:58 PM
0 · Reply
Joby099
Joby099 Mar. 11 at 3:22 PM
0 · Reply
Parobull
Parobull Mar. 11 at 1:59 PM
$ATPC $MRNO $VTAK POLA sitting right in the defense + drone tech narrative. Power systems used in military vehicles, robotics, and aerospace platforms. With drones becoming central to modern warfare and defense spending rising globally, small caps in this ecosystem can get attention quickly.…
0 · Reply
Stackdoe101
Stackdoe101 Mar. 11 at 1:31 PM
0 · Reply
DonCorleone77
DonCorleone77 Mar. 11 at 12:16 PM
$VTAK Catheter Precision secures up to $88M in institutional financing commitments Catheter Precision announced balance sheet improvements through new institutional capital commitments supporting the Company's next phase of growth. Fly Flyte, a newly acquired subsidiary of VTAK, is now positioned to execute its expansion strategy with a fully funded growth plan supported by its parent company, Catheter Precision. VTAK has recently completed multiple strategic financings designed to support the Company's transformation and the expansion of the Flyte aviation platform. The financing also provides capital to fund the Company's medical device operations. The Company's recent capital initiatives are expected to support the continued expansion of the Flyte platform and the Company's broader operational transformation. Capital intended to support: Fleet expansion and aircraft acquisitions Market expansion across additional regional corridors Scaling Flyte's aviation platform infrastructure Balance sheet simplification Reduction of legacy liabilities Management believes these initiatives position the Company as a more streamlined public company with significant exposure to the rapidly expanding regional aviation market.
0 · Reply
DARKP00L
DARKP00L Mar. 11 at 12:11 PM
$VTAK 08:04 on Mar. 11 2026 Catheter Precision Announces Transformational Balance Sheet Improvements Through New Institutional Capital Commitments Supporting Its Next Phase Of Growth #tradeideas
0 · Reply
_El_Capitan
_El_Capitan Mar. 11 at 12:07 PM
$VTAK Dilutive nonsense.
0 · Reply
LeveragedGrizzly
LeveragedGrizzly Mar. 11 at 12:02 PM
$VTAK time to take this ticker seriously!
1 · Reply
TheTradeXchange
TheTradeXchange Mar. 11 at 12:02 PM
$VTAK - Catheter Precision, Inc. Secures up to $88 Million in Strategic Institutional Financing Commitments to Fund Accelerated GrowthFully Funded Growth Strategy Supports Aircraft Fleet Expansion Providing Capacity to Service Current Demand in New Regions
0 · Reply
jstocks100
jstocks100 Mar. 11 at 10:54 AM
0 · Reply
SPARTANVI
SPARTANVI Mar. 11 at 8:02 AM
$AEHL $ATPC $VTAK AEHL potential next be early
0 · Reply
SPARTANVI
SPARTANVI Mar. 11 at 6:47 AM
$AEHL 760k float High CTB basically bottom here Reminds me of $ATPC $VTAK Has a crazy setup Nice potential here
0 · Reply
batmantradingzz
batmantradingzz Mar. 11 at 6:32 AM
$AEHL $VTAK $ACXP Aehl premarket potential
0 · Reply
trading_momentum_x
trading_momentum_x Mar. 11 at 5:40 AM
$VTAK shows a completed impulse into blue (3) followed by a sharp pullback into blue (4) at the $1.70–$1.75 demand zone, where price is now attempting to stabilize after the news-driven spike; if buyers reclaim $1.90 equilibrium, the next move could extend toward $2.05–$2.15 supply and potentially start a wave (5) continuation, but failure to hold $1.70 demand would invalidate the bounce and likely send price back toward $1.55 support despite the aviation acquisition catalyst and strong retail momentum.
0 · Reply
trading_momentum_x
trading_momentum_x Mar. 11 at 5:12 AM
$VTAK Bias: Bearish trend Structure: Downtrend with failed bounce. Key Levels Resistance: 2.00 / 2.10 Support: 1.70 / 1.55 Alpha: Only interesting above 2.10.
0 · Reply
VoidRequiem
VoidRequiem Mar. 11 at 12:45 AM
$VTAK bearish downtrend
0 · Reply